Tolergyx
French tech company | Builders Republic
About
Clinical-stage biotech developing oral immunotherapy capsules for food allergies — a peanut-allergy treatment that builds tolerance by releasing the allergen in the intestine instead of the mouth, reducing side effects, spun out of Clermont Auvergne academic research.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2025
- City
- CLERMONT-FERRAND
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 3.0 M€ raised since 2020
Funding rounds
- Seed — 2026
Investors
- Family Offices